Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.890
+0.040 (1.40%)
Nov 4, 2024, 4:00 PM EST - Market closed
Sunshine Biopharma Employees
Sunshine Biopharma had 44 employees as of December 31, 2023. The number of employees decreased by 2 or -4.35% compared to the previous year.
Employees
44
Change (1Y)
-2
Growth (1Y)
-4.35%
Revenue / Employee
$692,772
Profits / Employee
-$83,627
Market Cap
5.78M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Mainz Biomed | 71 |
Kindly MD | 65 |
Aethlon Medical | 14 |
Eterna Therapeutics | 8 |
CNS Pharmaceuticals | 5 |
Creative Medical Technology Holdings | 4 |
SBFM News
- 5 weeks ago - Sunshine Biopharma Launches Two New Generic Prescription Drugs - Accesswire
- 2 months ago - Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry - Accesswire
- 2 months ago - Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada - Accesswire
- 2 months ago - Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61% - Accesswire
- 3 months ago - Sunshine Biopharma Announces Reverse Stock Split - Accesswire
- 7 months ago - Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R) - Accesswire
- 7 months ago - Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023 - Accesswire
- 9 months ago - Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering - Accesswire